lisdexamfetamine dimesilate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
VYVANSE lisdexamfetamine dimesilate 60 mg capsules bottle
AUST R: 284021
Active ingredients:
lisdexamfetamine dimesilate

Dosage form:
Capsule, hard

Sponsor:
Takeda Pharmaceuticals Australia Pty Ltd

Phone:
1800012612

From
30 Aug 2024
to
17 Oct 2024

Shortage status:
Resolved

Availability:
Available

Reason:
Unexpected increase in consumer demand